sb 204070a has been researched along with tretinoin in 3 studies
Studies (sb 204070a) | Trials (sb 204070a) | Recent Studies (post-2010) (sb 204070a) | Studies (tretinoin) | Trials (tretinoin) | Recent Studies (post-2010) (tretinoin) |
---|---|---|---|---|---|
45 | 0 | 4 | 23,654 | 1,083 | 6,085 |
Protein | Taxonomy | sb 204070a (IC50) | tretinoin (IC50) |
---|---|---|---|
Bile salt export pump | Homo sapiens (human) | 10 | |
Amyloid-beta precursor protein | Homo sapiens (human) | 0.18 | |
Adenosine receptor A3 | Homo sapiens (human) | 5.275 | |
Retinoic acid receptor alpha | Homo sapiens (human) | 2.2542 | |
60 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 5.3 | |
Retinoic acid receptor beta | Homo sapiens (human) | 0.7537 | |
Retinoic acid receptor alpha | Mus musculus (house mouse) | 0.0057 | |
Retinoic acid receptor gamma | Homo sapiens (human) | 0.0064 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 5.275 | |
Retinoic acid receptor gamma | Mus musculus (house mouse) | 0.004 | |
Retinoic acid receptor beta | Mus musculus (house mouse) | 0.005 | |
Mitogen-activated protein kinase 1 | Homo sapiens (human) | 0.576 | |
Nuclear receptor ROR-alpha | Homo sapiens (human) | 0.1995 | |
Alpha-synuclein | Homo sapiens (human) | 3 | |
Cellular retinoic acid-binding protein 1 | Gallus gallus (chicken) | 0.5233 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.358 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 5.275 | |
Retinoic acid receptor RXR-gamma | Homo sapiens (human) | 0.35 | |
Nuclear receptor ROR-gamma | Homo sapiens (human) | 0.1995 | |
10 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 5.3 | |
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens (human) | 0.82 | |
60 kDa chaperonin | Escherichia coli | 6.7 | |
10 kDa chaperonin | Escherichia coli | 6.7 | |
Nuclear receptor ROR-beta | Homo sapiens (human) | 0.1259 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
3 other study(ies) available for sb 204070a and tretinoin
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |